4.7 Article

A single nucleotide polymorphism in the NCF1 gene leading to reduced oxidative burst is associated with systemic lupus erythematosus

期刊

ANNALS OF THE RHEUMATIC DISEASES
卷 76, 期 9, 页码 1607-1613

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/annrheumdis-2017-211287

关键词

-

资金

  1. Knut and Alice Wallenberg Foundation
  2. Swedish Rheumatism Association
  3. Swedish Medical Research Council
  4. Swedish Research Council
  5. Swedish Foundation for Strategic Research
  6. King Gustaf V's 80-Year Fund
  7. Alfred Osterlund, Greta and Johan Kock, Anna-Greta Crafoord and Swedish Heart-Lung
  8. Stockholm County Council
  9. Skane University Hospital (ALF)
  10. FOREUM Foundation
  11. European Union Innovative Medicine Initiative project BeTheCure

向作者/读者索取更多资源

Objectives Ncf1 polymorphisms leading to low production of reactive oxygen species (ROS) are strongly associated with autoimmune diseases in animal models. The human NCF1 gene is very complex with both functional and non-functional gene copies and genotyping requires assays specific for functional NCF1 genes. We aimed at investigating association and function of the missense single nucleotide polymorphism (SNP), rs201802880 (here denoted NCF1-339) in NCF1 with systemic lupus erythematosus (SLE). Methods We genotyped the NCF1-339 SNP in 973 Swedish patients with SLE and 1301 controls, using nested PCR and pyrosequencing. ROS production and gene expression of type 1 interferon-regulated genes were measured in isolated cells from subjects with different NCF1-339 genotypes. Results We found an increased frequency of the NCF1-339 T allele in patients with SLE, 11% compared with 4% in controls, OR 3.0, 95% CI 2.4 to 3.9, p=7.0x10(-20) The NCF1-339 T allele reduced extracellular ROS production in neutrophils (p=0.004) and led to an increase expression of type 1 interferon-regulated genes. In addition, the NCF1-339 T allele was associated with a younger age at diagnosis of SLE; mean age 30.3 compared with 35.9, p=2.0x1(-6). Conclusions These results clearly demonstrate that a genetically controlled reduced production of ROS increases the risk of developing SLE and confirm the hypothesis that ROS regulate chronic autoimmune inflammatory diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据